How Vaccine News Affects the Analysis of Its Company’s Stock Market: Based on Pfizer’s Big Data Analysis
Download as PDF
DOI: 10.23977/ICEMBE2022.017
Corresponding Author
Runlin Zhang
ABSTRACT
The COVID-19 epidemic is a devastating public health crisis around the world and many countries are suffering from the spread of its virus. In the COVID-19 pneumonia epidemic, China and the United States are the two most concerned countries in the world. A breakthrough has been made in the development of a vaccine for COVID-19. However, the COVID-19 vaccine’s false and misinformation symbiosis, the public opinion environment is bad, for the public. There are many adverse reactions to the effectiveness of the COVID-19 vaccine and vaccination. There are widespread concerns. But the countless challenges that media organizations face in journalism. In the face of war and crisis, he showed his tenacity and adaptability. Noodle in such an environment, how should the public media treat vaccine reports? There should be a continuing demand for the COVID-19 vaccine in the industry of vaccines and drugs. Taking the Pfizer company as an example, this paper discusses in detail how vaccine production affects its companies’ stock market.
KEYWORDS
Vaccine, Stock market, Pfizer